Cargando…

Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country

BACKGROUND: Though considered optimal, live cell-based assay (LCBA) is often unavailable for the diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) in resource-poor regions. This study was undertaken to determine the agreement between LCBA and the widely available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandit, Lekha, D’Cunha, Anitha, Malli, Chaithra, Sudhir, Akshatha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495565/ https://www.ncbi.nlm.nih.gov/pubmed/37705970 http://dx.doi.org/10.3389/fimmu.2023.1252650

Ejemplares similares

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
por: Malli, Chaithra, et al.
Publicado: (2023)

Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis – A Study from the Mangalore Demyelinating Disease Registry
por: DCunha, Anitha, et al.
Publicado: (2021)

Genetic variations in the Dravidian population of South West coast of India: Implications in designing case-control studies
por: D’Cunha, Anitha, et al.
Publicado: (2017)

Coexistence of Autoantibodies and Other Autoimmune Diseases with Multiple Sclerosis and Related Disorders – Experience from the Mangalore Demyelinating Disease Registry (MANDDIR)
por: Malli, Chaithra, et al.
Publicado: (2021)

CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population
por: D’Cunha, Mary Anitha, et al.
Publicado: (2016)

Serological markers associated with neuromyelitis optica spectrum disorders in South India
por: Pandit, Lekha, et al.
Publicado: (2016)

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
por: Pandit, Lekha, et al.
Publicado: (2016)

Environmental Factors Related to Multiple Sclerosis in Indian Population
por: Malli, Chaithra, et al.
Publicado: (2015)

Editorial: MOGAD, current knowledge and future trends
por: Siritho, Sasitorn, et al.
Publicado: (2023)

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4
por: Pandit, Lekha, et al.
Publicado: (2020)

COVID-19 infection and vaccination against COVID-19: Impact on managing demyelinating CNS disorders in Southern India- experience from a demyelinating disease registry.
por: Pandit, L., et al.
Publicado: (2022)

Not recommended fixed-dose antibiotic combinations in low- and middle-income countries – the example of Tanzania
por: Vliegenthart-Jongbloed, Klaske, et al.
Publicado: (2023)

Clinical and neuroimaging findings in MOGAD–MRI and OCT
por: Bartels, Frederik, et al.
Publicado: (2021)

Attack phenotypes and disease course in pediatric MOGAD
por: Santoro, Jonathan D., et al.
Publicado: (2023)

Incentivizing an exodus: The implications of recruiting nurses from low-middle income countries to high-income countries
por: Bortolussi-Courval, Émilie, et al.
Publicado: (2023)

Early hearing detection and intervention (EHDI) programmes for infants and young children in low-income and middle-income countries in Asia: a systematic review
por: Joshi B, Deepashree, et al.
Publicado: (2023)

Qualitative thallium urinary assays are almost as valuable as quantitative tests: implication for outpatient settings in low and middle income countries
por: Ghaderi, Amir, et al.
Publicado: (2017)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Low- and middle- income countries have a different illness profile
por: Gupta, Harish, et al.
Publicado: (2021)

Living and Dying With COVID-19 in South Asian Low- and Middle-Income Countries
por: Gyawali, Narayan, et al.
Publicado: (2021)

Data Equity to Advance Health and Health Equity in Low- and Middle-Income Countries: A Scoping Review
por: O‘Neil, So, et al.
Publicado: (2021)

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
por: Yandamuri, Soumya S., et al.
Publicado: (2023)

Palliative care services for cancer patients in Nepal, a lower-middle-income country
por: Gautam, Deepa, et al.
Publicado: (2021)

Is overseas volunteering beneficial to the NHS? The analysis of volunteers’ responses to a feedback questionnaire following experiences in low-income and middle-income countries
por: Yeomans, Daniel, et al.
Publicado: (2017)

Prevention of Drowning by Community-Based Intervention: Implications for Low- and Middle- Income Countries
por: Davoudi-Kiakalayeh, Ali, et al.
Publicado: (2012)

Dementia in low- and middle-income countries
por: Graham, Nori
Publicado: (2006)

Migration to middle-income countries and tuberculosis—global policies for global economies
por: Pescarini, Julia Moreira, et al.
Publicado: (2017)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries
por: Anderson, Carrie L., et al.
Publicado: (2016)

Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2
por: Graf, Jonas, et al.
Publicado: (2020)

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1
por: Graf, Jonas, et al.
Publicado: (2020)

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course
por: Rechtman, Ariel, et al.
Publicado: (2022)

Demystifying MOGAD and Double Seronegative NMOSD Further With IL-6 Blockade
por: Yong, Kok Pin, et al.
Publicado: (2021)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
por: Yao, Yajun, et al.
Publicado: (2022)

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
por: Fan, Xiao, et al.
Publicado: (2022)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
por: Du, Yangsa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eini19rjp89d3an17tipv5achh